Features of endovascular treatment of patients with NSTEMI

METHODS AND RESULTS: 346 patients were included and randomization. In I group (n=100), who were underwent complete myocardial revascularization during primary PCI procedure;in II group (n=124) - during hospitalization and III group(n=122) - in the delayed period following hospitalization. The additional randomization: Isubgroup(n=155)-PCI performed transradial access, IIsubgroup (n=191-PCI performed transfemoral access. Major bleeding (BARC 3 or 5) were 1, 2.4 and 1.6% respectively in group I, II and III (p>0.05). Ratio of major bleeding (BARC 3 or 5) were significantly higher in subgroup I and were 3.2%,whereas in subgroup II it were 0.52% (p=0.032).The cumulative MACE were 8.4and 1.6% respectively in subgroup I and II (p=0.001). The ratio of vascular complication were 3.87% in subgroup I and 7.33% in subgroup II (p=0.024). The cumulative MACE were 5 and 4.8%respectively in group I and II (p>0.05), but in group III MACE were 12.3% (p<0,001). CONCLUSION: the transradial access should be recommended as first-choice vascular access in patients with NSTEMI. The delayed complete myocardial revascularization differs power clinical outcomes, compared with the results of revascularization performed during hospitalization.